In fact, compared to the CCM1 or CCM2 mutations, CCM patients with the PDCD10 mutation usually have these features including more severe symptoms, earlier onset, and more rapid progression [67,68], which has also been observed in animal models with PDCD10 deletion [69]. This evidence concerns the gene PDCD10 and cerebral cavernous malformation.